You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 24, 2024

Investigational Drug Information for Pimodivir


✉ Email this page to a colleague

« Back to Dashboard


What is the development status for investigational drug Pimodivir?

Pimodivir is an investigational drug.

There have been 5 clinical trials for Pimodivir. The most recent clinical trial was a Phase 1 trial, which was initiated on January 3rd 2018.

The most common disease conditions in clinical trials are Influenza, Human, Liver Diseases, and Renal Insufficiency. The leading clinical trial sponsors are Janssen-Cilag International NV, Janssen Research & Development, LLC, and [disabled in preview].

There are eight US patents protecting this investigational drug and one hundred and thirty-two international patents.

Recent Clinical Trials for Pimodivir
TitleSponsorPhase
A Study of Orally Administered Pimodivir in Adult Participants With Renal ImpairmentJanssen-Cilag International NVPhase 1
A Study of Orally Administered Pimodivir in Adult Participants With Hepatic ImpairmentJanssen-Cilag International NVPhase 1
A Study to Evaluate the Effect of Cyclosporine, a P-Glycoprotein, Breast Cancer Resistance Protein, and Organic-Anion-Transporting Polypeptide Inhibitor, on Pimodivir in Healthy AdultsJanssen-Cilag International NVPhase 1

See all Pimodivir clinical trials

Clinical Trial Summary for Pimodivir

Top disease conditions for Pimodivir
Top clinical trial sponsors for Pimodivir

See all Pimodivir clinical trials

US Patents for Pimodivir

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Pimodivir ⤷  Sign Up Methods of preparing inhibitors of influenza viruses replication Vertex Pharmaceuticals Incorporated (Boston, MA) ⤷  Sign Up
Pimodivir ⤷  Sign Up Aza-pyridone compounds and uses thereof Alios BioPharma, Inc. (South San Francisco, CA) ⤷  Sign Up
Pimodivir ⤷  Sign Up Aza-pyridone compounds and uses thereof Alios BioPharma, Inc. (South San Francisco, CA) ⤷  Sign Up
Pimodivir ⤷  Sign Up Pyridazinone compounds and uses thereof ALIOS BIOPHARMA, INC. (South San Francisco, CA) ⤷  Sign Up
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Pimodivir

Drugname Country Document Number Estimated Expiration Related US Patent
Pimodivir Australia AU2014348752 2033-11-13 ⤷  Sign Up
Pimodivir Australia AU2019203656 2033-11-13 ⤷  Sign Up
Pimodivir Australia AU2021204970 2033-11-13 ⤷  Sign Up
Pimodivir Brazil BR112016010576 2033-11-13 ⤷  Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.